secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2026-02-10T23:59:59+00:00
Accession:  0001193125-26-044751
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud

Nektar Therapeutics reports $229.1M cash and investments as of Jan 31, 2026
---------------------------------------------------------------------------

- Cash and marketable securities totaled approximately $229.1 million as of January 31, 2026.
- Announcement made on February 10, 2026 via a Regulation FD disclosure.
- The amounts are estimates based on information available as of the announcement date.
- Nektar Therapeutics (ticker: NKTR) listed on the Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000119312526044751/0001193125-26-044751-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000119312526044751/d40599d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-044751

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer